Enobia Pharma's Grant

Enobia Pharma raised a round of funding on March 28, 2009. Investors include Qualifying Therapeutic Discovery Project.

Enobia Pharma develops therapies to treat serious genetic bone disorders for which there are no approved treatments. The company's lead product, ENB-0040 (human recombinant tissue non-specific alkalin…

Articles about Enobia Pharma's Grant: